Permissible Outcomes of Lobe-Specific Lymph Node Dissection for Elevated Carcinoembryonic Antigen in Non-Small Cell Lung Cancer

<i>Background and Objectives</i><i>:</i> Lobe-specific nodal dissection (L-SND) is currently acceptable for the dissection of early-stage non-small cell lung cancer (NSCLC) but not for cancers of more advanced clinical stages. We aimed to assess the efficacy of L-SND, compare...

Full description

Bibliographic Details

Published in:	Medicina
Main Authors:	Hiroaki Kuroda, Junji Ichinose, Katsuhiro Masago, Yusuke Takahashi, Takeo Nakada, Masayuki Nakao, Sakae Okumura, Kohei Hashimoto, Yosuke Matsuura, Noriaki Sakakura, Hirokazu Matsushita, Mingyon Mun
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Subjects:	non-small cell lung cancer lobe-specific lymph node dissection systemic lymph node dissection carcinoembryonic antigen lobectomy
Online Access:	https://www.mdpi.com/1648-9144/57/12/1365